Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation

M. Dong, A. K. Parsaik, N. L. Eberhardt, A. Basu, F. G. Cosio, Y. C. Kudva

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


New-onset diabetes after transplantation is recognized as one of the metabolic consequences which may increase the risk of morbidity and mortality after solid organ transplantation. The pathophysiology of new-onset diabetes after transplantation has not been clearly defined and may resemble that of Type 2 diabetes, characterized by predominantly insulin resistance or defective insulin secretion, or both. This review aims to summarize the current state of knowledge regarding the prevalence, consequences, pathogenesis, and management of new-onset diabetes after transplantation, with a major focus on the possible mechanisms involved in the pathogenesis of the disorder. The aetiology of new-onset diabetes after transplantation is multifactorial, with diabetogenic immunosuppressive drugs playing a major role. Multiple cellular and physiologic mechanisms are involved in the process. Selection of an appropriate maintenance immunosuppressive regimen should involve balancing the risk of patient and graft survival vs. the potential for new-onset diabetes after transplantation.

Original languageEnglish (US)
Pages (from-to)e1-e12
JournalDiabetic Medicine
Issue number7
StatePublished - Jul 2012


  • Diabetes mellitus
  • Mechanism
  • New onset
  • Organ transplantation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation'. Together they form a unique fingerprint.

Cite this